Hydrolysis of 2D Nanosheets Reverses Rheumatoid Arthritis Through Anti‐Inflammation and Osteogenesis
Advanced Materials · 2025-02 · 37 (7)
DOI: 10.1002/adma.202415543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 26.12.2024. Verfasst von Penghao Ji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Shanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedica…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Osteogenesis, Anti-Inflammatory Agents, Nanoparticles. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Key Research Program of Frontier Sciences, Chinese Academy of Sciences.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a kind of inflammation homeostasis disorder that dysfunctions the joints. Clinically, medications against RA focus simply on mitigating the focal inflammation, without considering pro‐osteogenesis re‐modeling of the bone microenvironment. In the present work, 2D layered calcium disilicide nanoparticles (CSNs) are fabricated by facile aqueous exfoliation. The hydrolysis of CSNs produces anti‐oxidative H 2 , alkaline Ca(OH) 2 , and silica. These moieties play significant roles in anti‐oxidation, anti‐inflammation, and pro‐osteogenesis resulting in considerably better RA therapeutic consequences than anti‐inflammation alone. Hydrogen gas is validated to eliminate excessive hydroxyl radicals and regulate macrophage re‐polarization; the generated Ca(OH) 2 can neutralize the acidic microenvironment and inhibit the osteoclast activity; and, the dissolved Ca 2+ can effectively complex with phosphates to mineralize Ca 3 (PO 4 ) 2 , promoting the osteogenesis of the focal joint. The multifunctional performances of CSNs are further confirmed in arthritic mouse and rabbit models, providing an advanced and robust therapeutic strategy against RA with high biocompatibility and clinical transformable promises.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Shanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering & Nano Science School of Medicine, School of Medicine, T…
- State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics Chinese Academy of Sciences, Research Unit of Nanocatalytic Medicine in Specific Therapy for Serious Disease…
ORCID-Profile: Minfeng Huo, Jianlin Shi
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Key Research Program of Frontier Sciences, Chinese Academy of Sciences
- Basic Research Program of Shanghai Municipal Government
- Shanghai Municipal Health Commission Clinical Research General Project
- Shanghai Rising-Star Program
- Research Unit of Nanocatalytic Medicine in Specific Therapy for Serious Disease, Chinese Academy of Medical Sciences
- National Key Research and Development Program of China
Zitieren
APA
Ji, P., Qiu, S., Huang, J., Wang, L., Wang, Y., Wu, P., Huo, M., & Shi, J. (2025). Hydrolysis of 2D Nanosheets Reverses Rheumatoid Arthritis Through Anti‐Inflammation and Osteogenesis. Advanced Materials, 37(7). https://doi.org/10.1002/adma.202415543
Vancouver
Ji P, Qiu S, Huang J, Wang L, Wang Y, Wu P, et al. Hydrolysis of 2D Nanosheets Reverses Rheumatoid Arthritis Through Anti‐Inflammation and Osteogenesis. Advanced Materials. 2025;37(7). doi:10.1002/adma.202415543
BibTeX
@article{Ji2025,
author = {Ji, Penghao and Qiu, Shuwen and Huang, Junchao and Wang, Liping and Wang, Yuemei and Wu, Peng and Huo, Minfeng and Shi, Jianlin},
title = {Hydrolysis of 2D Nanosheets Reverses Rheumatoid Arthritis Through Anti‐Inflammation and Osteogenesis},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {7},
doi = {10.1002/adma.202415543}
}
EUVIMED